Hanugen Therapeutics Private Limited

Hanugen Therapeutics Private Limited - life sciences in Bangalore North, Karnataka, India. FY 2026 financials and compliance.
CIN U73200KA2017PTC100686 Incorporated 20 February 2017 ROC Bangalore HQ Bangalore North, Karnataka, India
Active Private Limited Company life sciences
Data last updated
Revenue · FY 2025
₹1.23 Cr
▲ 23.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
9 yrs
Est. 2017
Last financials
Mar 2025
Balance sheet date

About Hanugen Therapeutics Private Limited

Data last updated: 26 February 2026

Hanugen Therapeutics Private Limited is a private limited company based in Bangalore North, Karnataka, India, recognised as a startup by DPIIT. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 20 February 2017, the company has been in operation for over 9 years.

Registered with ROC Bangalore under CIN U73200KA2017PTC100686.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Arun Shastry and Manjulam.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Bangalore North, Karnataka.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.23 Cr, a growth of 23% compared to the previous year.

The company is associated with 1 brand - Hanugen Therapeutics.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hanugen.com.

Company Details of Hanugen Therapeutics Private Limited
CIN U73200KA2017PTC100686
Registration Number 100686
Incorporation Date 20 February 2017
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    No. 7 Balaji Arcade 3Rd Floor Chikkamaranahalli, Opp Hp Petrol Bunk New Bel Road, Bangalore North, Karnataka, India – 560094
  • Industry
    Life Sciences, Biotechnology
Company report
Hanugen Therapeutics Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Hanugen Therapeutics Private Limited report

Financials, compliance, directors, charges, ownership and filings for Hanugen Therapeutics Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Hanugen Therapeutics Private Limited

Hanugen Therapeutics Private Limited operates one associated brand: Hanugen Therapeutics. These brands represent Hanugen Therapeutics Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Oligonucleotide therapeutics are developed for rare genetic disorders treatment. hanugen.com

Competitors & Alternatives of Hanugen Therapeutics Private Limited

Brands and companies operating in the same space as Hanugen Therapeutics Private Limited include Spark Therapeutics, BridgeBio, Forge Biologics and 6 more.

Competitor Description Location Founded
Spark Therapeutics Spark Therapeutics Gene therapies for rare diseases including retinal dystrophies are developed. Philadelphia, United States, United States 2013
BridgeBio BridgeBio Therapeutics for genetic diseases are developed through targeted interventions. Palo Alto, United States, United States 2015
Forge Biologics Forge Biologics Gene therapies for rare diseases are developed to treat patients. Columbus, United States, United States 2020
Insitro Insitro An AI-enabled platform is developed for infectious disease treatment. San Francisco, United States, United States 2018
Alnylam Alnylam RNA interference-based therapeutics are developed for multiple disorders. Cambridge, United States, United States 2002
Caribou Biosciences Caribou Biosciences Provider of cell therapies to treat cancer and hematologic conditions Berkeley, United States, United States 2011
Ultragenyx Ultragenyx Therapeutics for rare and ultra-rare metabolic diseases are developed. Novato, United States, United States 2010
Chimerix Chimerix Antiviral oral therapeutics are developed for infectious diseases and cancers. Durham, United Kingdom, United Kingdom 2002
ATAI ATAI A biopharmaceutical company accelerating innovative mental health treatments. Munich, Germany, Germany 2018

Business Activity of Hanugen Therapeutics Private Limited

Hanugen Therapeutics Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including other professional, scientific and technical activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M9 Other professional, scientific and technical activities Locked
Premium access

Business activity turnover details for Hanugen Therapeutics Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Hanugen Therapeutics Private Limited

Hanugen Therapeutics Private Limited is audited by SAI GANESH KARTHIK & ASSOCIATES for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
SAI GANESH KARTHIK & ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Hanugen Therapeutics Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Hanugen Therapeutics Private Limited

Hanugen Therapeutics Private Limited is governed by 3 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Arun Shastry Director 20 Feb 2017 9 Years 5 Months Current
Manjulam Director 20 Feb 2017 9 Years 5 Months Current
Rav Deep Singh Anand Director 20 Feb 2017 9 Years 5 Months Current

Financials of Hanugen Therapeutics Private Limited FY 2025 filings available

Hanugen Therapeutics Private Limited reported revenue of ₹1.23 Cr (up 23.00% YoY) for FY 2025.

Revenue · FY 2025
₹1.23 Cr ▲ 23.00%
Premium access

Ten-year financial statements for Hanugen Therapeutics Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Hanugen Therapeutics Private Limited

Premium access

Shareholding and ownership data for Hanugen Therapeutics Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Hanugen Therapeutics Private Limited

Hanugen Therapeutics Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Hanugen Therapeutics Private Limited

View historical data on people associated with Hanugen Therapeutics Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Hanugen Therapeutics Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Hanugen Therapeutics Private Limited

Premium access

GST registrations and filing compliance for Hanugen Therapeutics Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Hanugen Therapeutics Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Hanugen Therapeutics Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Hanugen Therapeutics Private Limited

Premium access

MSME payment history for Hanugen Therapeutics Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Hanugen Therapeutics Private Limited

Premium access

Corporate group structure for Hanugen Therapeutics Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Hanugen Therapeutics Private Limited

Premium access

MCA filings and documents for Hanugen Therapeutics Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Hanugen Therapeutics Private Limited

Activity
30 Sep 2025
Hanugen Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Hanugen Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Directors
20 Feb 2017
Arun Shastry was appointed as a Director on 20 Feb 2017 & has been associated with this company since 9 years 5 months.
Directors
20 Feb 2017
Manjulam was appointed as a Director on 20 Feb 2017 & has been associated with this company since 9 years 5 months.
Directors
20 Feb 2017
Rav Deep Singh Anand was appointed as a Director on 20 Feb 2017 & has been associated with this company since 9 years 5 months.
Activity
20 Feb 2017
Hanugen Therapeutics Private Limited was registered on 20 Feb 2017 with Roc Bangalore & aged 9 years 5 months as per MCA records.

Frequently Asked Questions about Hanugen Therapeutics Private Limited

Hanugen Therapeutics Private Limited is an active private limited company in the life sciences sector based in Bangalore North, Karnataka, India. It was incorporated on 20 February 2017 (9+ years old) and is registered under CIN U73200KA2017PTC100686.

Hanugen Therapeutics Private Limited reported revenue of ₹1.23 Cr for FY 2025 (up 23.00% YoY).

The current directors of Hanugen Therapeutics Private Limited are:

The primary industry of Hanugen Therapeutics Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.

Yes, Hanugen Therapeutics Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Hanugen Therapeutics Private Limited can be reached at the registered office: No. 7 Balaji Arcade 3Rd Floor Chikkamaranahalli, Opp Hp Petrol Bunk New Bel Road, Bangalore North, Karnataka, India – 560094, or through the website hanugen.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available